aTyr Pharma Inc. Common Stock (ATYR)
Stock · NASDAQ · Health Care
$0.5361as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$0.824638
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
aTyr Pharma Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ATYRaTyr Pharma Inc. Common Stock$0.5361▼ 3.41%Market cap $49.22MP/E —
- TILInstil Bio Inc. Common Stock$7.58▼ 3.56%Market cap $49.37MP/E —$5.67$33.83
- EXOZeXoZymes Inc. Common Stock$7.17▼ 0.10%Market cap $47.57MP/E —$4.35$18.4
- MGXMetagenomi Therapeutics Inc. Common Stock$1.2▼ 0.83%Market cap $46.68MP/E —
- OKYOOKYO Pharma Limited Ordinary Shares$1.67▲ 7.74%Market cap $51.94MP/E —$1.34$3.2
- INKTMiNK Therapeutics Inc. Common Stock$11.43▼ 2.16%Market cap $54.80MP/E —$8.48$16.98
- TVGNTevogen Inc. Common Stock$6.89▲ 2.07%Market cap $41.58MP/E —$3.64$49.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ATYR aTyr Pharma Inc. Common Stock | $49.22M | — | $0.5361 | ▼ 3.41% | |
| TIL Instil Bio Inc. Common Stock | $49.37M | — | $7.58 | ▼ 3.56% | $5.67$33.83 |
| EXOZ eXoZymes Inc. Common Stock | $47.57M | — | $7.17 | ▼ 0.10% | $4.35$18.4 |
| MGX Metagenomi Therapeutics Inc. Common Stock | $46.68M | — | $1.2 | ▼ 0.83% | |
| OKYO OKYO Pharma Limited Ordinary Shares | $51.94M | — | $1.67 | ▲ 7.74% | $1.34$3.2 |
| INKT MiNK Therapeutics Inc. Common Stock | $54.80M | — | $11.43 | ▼ 2.16% | $8.48$16.98 |
| TVGN Tevogen Inc. Common Stock | $41.58M | — | $6.89 | ▲ 2.07% | $3.64$49.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Institutional Ownership
March 31, 2026
- Total shares held
- 55.66M
- Total value held
- $42.03M
- Institutional holders
- 109
Top holders this quarter
- Unknown14.71M
- Unknown10.51M
- Unknown6.44M
- Unknown3.87M
- Unknown3.81M
- Unknown2.39M
- Unknown1.75M
- Unknown1.68M
- Unknown1.64M
- Unknown1.23M
See the full, filterable feed with live charts on the MarketWall dashboard.